Image

Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients

Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China, and validated it across five independent, geographically distinct, different tiered hospitals.

Description

Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China using the machine learning technique, and then validated the performance of the prediction model across five independent, geographically distinct, different tiered hospitals in China.

Eligibility

Inclusion Criteria:

  • Adult patients (18 years and older) admitted to five hospitals during the study period

Exclusion Criteria:

  • Have less than 2 documented serum creatinine (Scr) measurements during hospitalization
  • Being diagnosed with end-stage renal disease (ESRD)
  • Maintained on dialysis or had an initial Scr greater than or equal to 4.0 mg/dL at admission
  • Developed AKI prior to admission or within 24 hours after admission
  • Length of stay shorter than 24 hours
  • Underwent kidney transplantation or nephrectomy during hospitalization
  • With all Scr measurements lower than or equal to 0.6 mg/dL from 90 days prior to admission until discharge.

Study details
    Prediction Model

NCT06597838

Peking University First Hospital

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.